Founded in 1901 by Gedeon Richter, the plant was transformed into a business entity in 1923. Since 1997, it has been the largest domestic drug manufacturer. Its main activity is the manufacturing and distribution of active ingredients and generic pharmaceuticals. Richter has now grown into a multinational company of the Central and Eastern European region. Due to a market network unique in the region and covering five continents, the company s products are available in nearly one hundred countries worldwide. Also unique among Hungarian companies is its network of market interests, comprising the member states of the European Union, the United States of America, the CIS states, Japan and the Eastern region. It operates an extensive marketing and distribution network in Hungary, the CIS states and Eastern Europe.
Note: When determining the Free Float for a particular series, all the securities of the company shall be regarded to be publicly held other than (i) the stock of securities held by holders with direct holdings of at least 5% of the total number of securities, (ii) securities in the possession of custodians, provided the certificate available to the custodian verifies that the particular person holds at least 5% of the total number of securities outstanding.
Management
Management Board
William de GELSEY (chairman), BOGSCH Erik, dr. GULÁCSI Gábor, HORVÁTH Gergely, dr. KOLTAY Jenő, dr. KOVÁCS László, LANTOS Csaba, Christopher William LONG, dr. MÉSZÁROS Tamás, dr. PERJÉS Gábor, Prof. Dr. VIZI E. Szilveszter
Management
BOGSCH Erik (CEO), dr. GULÁCSI Gábor (deputy CEO), KOVÁCS Lajos (technical director), KOVÁTS Sándor (commerce director), RADÓ András (deputy CEO and production and logistics director), dr. SZOMBATHELYI Zsolt (research director), dr. THALER György (development director)
Supervisory Board
dr. CHIKÁN Attila (chairman), BALASKÓ András, dr. BEDROS Jonathán Róbert, ERŐS József, FODOR Jenő, dr. JÁNOKINÉ dr. BALOGH Mária, MÉHÉSZ Tamásné, dr. SIMON KIS Gábor, SUGÁR S. András, TÓTH Gábor
